Mr Phillip Ramsey

CTO at Sangamo Therapeutics

Speaker

Phillip Ramsey is Chief Technology Officer at Sangamo where he oversees manufacturing, technical development, supply chain, and quality. He was previously the Senior Vice President overseeing Technical Operations and prior to that the Vice President of Technical Development overseeing process and analytical development, vector delivery and CMC program management. Phillip has over 35 years of experience in product development, operations, and quality.

Prior to Sangamo Phillip was with Emergent BioSolutions in increasing roles of responsibility most recently Senior Director in the Biodefense division and helped design and facilitate construction of the CIADM facility in collaboration with BARDA. The facility was awarded the runner-up 2018 FOYA award for innovative design. While at Emergent he was involved with multiple commercial products, M&A activities, and their CDMO business.

Prior to this he was at Leidos where he participated in the design and construction of a 130,000 square foot vaccine pilot plant for the NIH. He has contributed to multiple regulatory submissions for product approval and more than 50 investigational new drug submissions.

Phillip received a BS in Chemistry from the University of Nebraska, a MS in Biochemistry from John Hopkins University and an MBA from San Diego State University. He has been active in multiple therapeutic areas including oncology, vaccines, infectious diseases, CNS, and rare diseases. He has worked on a variety of technologies including proteins, monoclonal antibodies, cell and gene therapy, genome editing, LNPs, bispecific antibodies, and immunotherapies.